Search

M2 PRESSWIRE-November 22, 2024-: Axial Spondyloarthritis Therapeutics Market Size was ~USD 9 Million in 2023, estimated DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:21112024 DelveInsight's 'Axial Spondyloarthritis Market Insights, Epidemiology and Market Forecast-2034' [...]

M2 PRESSWIRE-October 23, 2024-: Axial Spondyloarthritis Market on Track for Major Expansion by 2034, According to DelveInsight | UCB Biopharma, Celgene, Novartis, Pfizer, Merck, Inmagene Biopharma, Galapagos NV, Kyowa Kirin [...]

M2 PRESSWIRE-May 2, 2024-: Atopic Dermatitis Market to Witness an Upsurge in Growth by 2032, Examines DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:01052024 DelveInsight's 'Atopic Dermatitis Market Insights, Epidemiology, and Market Forecast [...]

M2 PRESSWIRE-April 24, 2024-: Rheumatoid Arthritis Market to Witness Upsurge in Growth During the Forecast Period (2024-2034), Examines DelveInsight | AbbVie, Pfizer, Regeneron/Sanofi, Eli Lilly and Company, UCB BIOSCIENCES GmbH [...]

M2 PRESSWIRE-April 24, 2024-: Global Kinase Inhibitors in Autoimmune Diseases Market Analysis 2032: Epidemiology, Clinical Trials, Companies & Growth Analysis by DelveInsight | Pfizer, Eli Lilly, AbbVie, Janssen, Novartis, Gilead [...]

M2 PRESSWIRE-April 18, 2024-: Juvenile Idiopathic Arthritis Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examines DelveInsight | AbbVie, Pfizer, Regeneron/Sanofi, Eli Lilly and Company, UCB Pharma [...]

M2 PRESSWIRE-February 14, 2024-: Janus kinase (JAK) Inhibitor Market to Witness Upsurge in Growth During the Study Period (2020-2034), Assesses DelveInsight | Companies to Look Out - Pfizer, Sierra Oncology, [...]

(GlobeNewswire) - The 'XELJANZ Market Drug Insight and Market Forecast - 2032' drug pipelines has been added to ResearchAndMarkets.com's offering. 'XELJANZ Market Drug Insight and Market Forecast - 2032' report [...]

M2 PRESSWIRE-October 25, 2023-: Glioma Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Denovo, Pfizer, Chimerix, AiVita, Ascletis, Immunomic, Roche, Vigeo (C)1994-2023 [...]

Dublin: Research and Markets has issued the following news release: The 'Tofacitinib Global Market Report 2023' report has been added to ResearchAndMarkets.com's offering. The global tofacitinib market is expected to [...]

(GlobeNewswire) - The 'Tofacitinib Global Market Report 2023' report has been added to ResearchAndMarkets.com's offering. The global tofacitinib market is expected to grow from $2.43 billion in 2022 to $2.76 [...]

(GlobeNewswire) - The 'Ankylosing Spondylitis Global Market Report 2023' report has been added to ResearchAndMarkets.com's offering. The global ankylosing spondylitis market is on a growth trajectory, with projections indicating an [...]

(GlobeNewswire) - Zion Market Research has published a new research report titled Atopic Eczema Treatment Market - By Drug Class (Biologics And PDE4 Inhibitors), By Route Of Administration (Topical, Injectable, [...]

New York, NY, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled 'Atopic Eczema Treatment Market - By Drug Class (Biologics And PDE4 [...]

M2 PRESSWIRE-July 13, 2023-: Inflammatory Myositis Market is Expected to Expand at a Healthy Growth Rate During the Study Period (2019 -2032)|Key Companies - CSL Behring, Immunoforge Co. Ltd., Argenx [...]

M2 PRESSWIRE-June 6, 2023-: Global Kinase Inhibitors in Autoimmune Diseases Market to Witness Growth by 2032, Estimates DelveInsight | Pfizer, Eli Lilly, AbbVie, Janssen, Novartis, Gilead Sciences, Astellas Pharma, Japan [...]

M2 PRESSWIRE-May 30, 2023-: Ankylosing Spondylitis (Bekhterev's Disease) Pipeline Insight | Companies - Fresenius Kabi, Shanghai Henlius Biotech, Pfizer, Fujifilm Kyowa Kirin Biologics, Hetero Biopharma, and Others (C)1994-2023 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-May 29, 2023-: Ankylosing Spondylitis (Bekhterev's Disease) Pipeline Insight | Companies - Fresenius Kabi, Shanghai Henlius Biotech, Pfizer, Fujifilm Kyowa Kirin Biologics, Hetero Biopharma, Bio-Thera Solutions (C)1994-2023 M2 COMMUNICATIONS [...]

New York, USA, May 17, 2023 (GLOBE NEWSWIRE) -- Propulsion of Glioma Clinical Trial Pipeline as Novel and Extensive 220+ Therapies Likely to Enter in the Treatment Domain | DelveInsight [...]

M2 PRESSWIRE-November 17, 2022-: Global Kinase Inhibitor in Autoimmune Diseases Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market (C)1994-2022 M2 COMMUNICATIONS RDATE:16112022 DelveInsight's 'Global Kinase [...]

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's 'JAK Inhibitors Competitive Landscape - 2022' report provides comprehensive global coverage of available, marketed, and pipeline JAK [...]

JAK inhibitors clinical trial pipeline constitutes 40+ key companies continuously working towards developing 45+ JAK inhibitor drugs, analyzes DelveInsight LAS VEGAS, Nov. 15, 2022 /PRNewswire/ -- DelveInsight's' https://www.delveinsight.com/report-store/janus-kinase-jak-inhibitors-competitive-landscape?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr' report provides [...]

M2 PRESSWIRE-September 23, 2022-: Ankylosing Spondylitis Market Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market (C)1994-2022 M2 COMMUNICATIONS RDATE:22092022 DelveInsight's 'Ankylosing Spondylitis (AS)-Market Insights, Epidemiology, and [...]

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: The expected launch of potential therapies such as Abrocitinib/ PF-04965842, ARQ-151 (Roflumilast cream), Lebrikizumab (LY3650150), Etrasimod (APD334), FB825, [...]

LAS VEGAS, Feb. 14, 2022 /PRNewswire/ -- The expected launch of potential therapies such as Abrocitinib/ PF-04965842, ARQ-151 (Roflumilast cream), Lebrikizumab (LY3650150), Etrasimod (APD334), FB825, Nemolizumab (CD14152), DS107, Bermekimab, KY1005, [...]

DUBLIN: Research and Markets has issued the following news release: The 'Global Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By [...]

DUBLIN, Jan. 18, 2022 /PRNewswire/ -- The 'Global Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Regional Outlook, Industry Analysis [...]

New York, Oct 19, 2021 (GLOBE NEWSWIRE via COMTEX) -- Reportlinker.com announces the release of the report 'Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report By Type, [...]

Los Angeles, USA, Sep 22, 2021 (GLOBE NEWSWIRE via COMTEX) -- Scleroderma Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising a Broad Spectrum of Molecular Targets There are more [...]

Dublin, Aug 20, 2021 (GLOBE NEWSWIRE via COMTEX) -- The 'Psoriatic Arthritis - Market Insight, Epidemiology and Market Forecast - 2030' report has been added to ResearchAndMarkets.com's offering. This 'Psoriatic [...]

Dublin, Aug 11, 2021 (GLOBE NEWSWIRE via COMTEX) -- The 'Alopecia Market Size, Share & Trends Analysis Report by Disease Type (Alopecia Areata, Cicatricial, Traction, androgenetic Alopecia), by Treatment, by [...]

New York, Aug 05, 2021 (GLOBE NEWSWIRE via COMTEX) -- Reportlinker.com announces the release of the report 'Alopecia Market Size, Share & Trends Analysis Report By Disease Type, By Treatment, [...]

Research and Markets has announced the addition of the 'Global Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Regional Outlook, [...]

Los Angeles, June 17, Jun 17, 2021 (GLOBE NEWSWIRE via COMTEX) -- Axial Spondyloarthritis Pipeline: Drug Pipeline, Regulatory Events and Clinical Trials in the Spotlight| Insights by DelveInsight The report [...]

Dublin, Jan 12, 2021 (GLOBE NEWSWIRE via COMTEX) -- The 'Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2029' report has been added to ResearchAndMarkets.com's offering. Global revenues [...]

New York, Jan 11, 2021 (GLOBE NEWSWIRE via COMTEX) -- Reportlinker.com announces the release of the report 'Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2029' - https://www.reportlinker.com/p05773541/?utm_source=GNW [...]

M2 PRESSWIRE-April 6, 2020-: Global $5.3 Bn Alopecia Markets by Disease Type, Gender, End-use, Sales Channel and Region - Forecast to 2027 (C)1994-2020 M2 COMMUNICATIONS RDATE:06042020 The 'Alopecia Market Size, [...]

Research and Markets has announced the addition of the 'Alopecia Market Size, Share & Trends Analysis Report 2021 - 2028' report to its offerings. In a release, Research and Markets [...]

NEW YORK: Reportlinker has issued the following press release: Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028 Summary Read the full report: https://www.reportlinker.com/p05827504/?utm_source=PRN Axial spondyloarthritis (axSpA) is a [...]

NEW YORK, Nov. 19, 2019 /PRNewswire/ -- Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028 Summary Read the full report: https://www.reportlinker.com/p05827504/?utm_source=PRN Axial spondyloarthritis (axSpA) is a disease group [...]

NEW YORK: ReportBuyer has issued the following news release: Alopecia Market Size, Share & Trends Analysis Report By Disease Type, By End Use (Homecare Settings, Dermatology Clinics), By Sales Channel [...]

NEW YORK, Aug. 20, 2019 /PRNewswire/ -- Alopecia Market Size, Share & Trends Analysis Report By Disease Type, By End Use (Homecare Settings, Dermatology Clinics), By Sales Channel (OTC, Prescription), [...]

Dublin: Research and Markets has issued the following news release: The 'Psoriatic Arthritis Market and Forecast Analysis 2035' report has been added to ResearchAndMarkets.com's offering. Psoriatic arthritis (PsA) is an [...]

DUBLIN: Research and Markets has issued the following press release: The 'Psoriatic Arthritis Market and Forecast Analysis 2035' report has been added to ResearchAndMarkets.com's offering. Psoriatic arthritis (PsA) is an [...]